Sterling Knight Ipamorelin 1 vial (10 mg) EXPIRATION

Ipamorelin

Peptide Ghrelin is a selective agonist of the Growth Hormone Secretagogue Receptor (GHSR) and a growth hormone secretagogue. This pentapeptide has the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2, derived from GHRP-1.

How it Works

Ipamorelin activates GHSR, leading to a biological response. Located in the ventromedial nucleus of the hypothalamus (VMN), the receptor regulates energy homeostasis and modulates calorie intake and body weight.

Benefits

• Unlike other peptides, Ipamorelin does not influence prolactin (PRL), a hormone vital for lactation, immune regulation, and pancreatic development.
• No adverse effects on Follicle-Stimulating Hormone (FSH) or Luteinizing Hormone (LH) levels have been reported. FSH and LH are crucial for reproductive health in both men and women.
• Furthermore, Ipamorelin has no reported impact on Thyroid-Stimulating Hormone (TSH), which is essential for metabolism and stabilizing thyroid hormone levels, thus preventing disorders like hyperthyroidism and hypothyroidism.
• This peptide does not stimulate Adrenocorticotropic Hormone (ACTH) secretion, which can elevate cortisol levels and compromise immune response.
• No cortisol-related side effects have been associated with Ipamorelin. Cortisol’s role is critical in managing insulin balance and stress responses, making this peptide advantageous for stress management.
• Cortisol is also involved in regulating blood pressure and immune function—key components for overall health.

Dosage

The typical dosage of Ipamorelin ranges from 200 to 300 mcg, administered 2 to 3 times daily, often in cycles lasting twelve weeks.

• Recommended frequency: 2-3 times per day.
• Preferred injection site: fat around the abdomen.
• Injection dosage: 200-300 mcg per session.